Suchergebnisse - "Schuster, Sabine"

PubPharm (44)

1

A METHOD OF MODIFYING AN ORGANIC CYTOTOXIN FOR USE AS A PAYLOAD IN AN ANTIBODY-DRUG CONJUGATE AND MODIFIED ORGANIC CYTOTOXINS DERIVED THEREFROM

enthalten in: Europäisches Patentamt | 2024

von ENKE HEIKE | ENKE DAN | NIEDERMEYER TIMO | +2

2

A METHOD OF MODIFYING AN ORGANIC CYTOTOXIN FOR USE AS A PAYLOAD IN AN ANTIBODY-DRUG CONJUGATE AND MODIFIED ORGANIC CYTOTOXINS DERIVED THEREFROM

enthalten in: Europäisches Patentamt | 2024

von ENKE HEIKE | ENKE DAN | NIEDERMEYER TIMO | +2

3

A METHOD OF MODIFYING AN ORGANIC CYTOTOXIN FOR USE AS A PAYLOAD IN AN ANTIBODY-DRUG CONJUGATE AND MODIFIED ORGANIC CYTOTOXINS DERIVED THEREFROM

enthalten in: Europäisches Patentamt | 2024

von ENKE HEIKE | ENKE DAN | NIEDERMEYER TIMO | +2

4

Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds

enthalten in: Microbiology spectrum | 2024

von Schuster, S. | Vavra, M. | Wirth, D. | +1

5

Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy : An Overview

enthalten in: International journal of molecular sciences | 2024

von Mező, G. | Gomena, J. | Ranđelović, I. | +11

6

A Screening of Antimalarials Extends the Range of Known Escherichia coli AcrB Efflux Substrates and Reveals Two Candidates with Antimicrobial Drug-Enhancing Activity

enthalten in: Microbial drug resistance (Larchmont, N.Y.) | 2022

von Schuster, S. | Vavra, M. | Kern, W.

7

Surveillance and Genomic Analysis of Third-Generation Cephalosporin-Resistant and Carbapenem-Resistant Klebsiella pneumoniae Complex in Germany

enthalten in: Antibiotics (Basel, Switzerland) | 2022

von Xanthopoulou, K. | Imirzalioglu, C. | Walker, S. | +39

8

Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates

enthalten in: International journal of molecular sciences | 2022

von Schuster, S. | Juhász, �. | Halmos, G. | +3

9

Protein engineering of a stable and potent anti-inflammatory IL-37-Fc fusion with enhanced therapeutic potential

enthalten in: Cell chemical biology | 2022

von Bujotzek, A. | Tiefenthaler, G. | Lariviere, L. | +19

10

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial

enthalten in: Wiener klinische Wochenschrift | 2021

von Kremsner, P. | Mann, P. | Kroidl, A. | +56

1
2
3
4
5
Nächster »
[5]